Clinical RCT 2014 Phase 2b RCT in postoperative ileus (bowel resection inpatients) Beck, Sweeney, and McCarter (Ipamorelin 201 Study Group) reported a multicenter, double-blind, placebo-controlled proof-of-concept study in bowel-resection inpatients
Simon, L., Zini, A., Dyachenko, A., Ciampi, A
Available via injections, cream and dissolvable troches
Gentle Cleansing: Effectively cleanses the skin without stripping its natural moisture, making it suitable for daily use
However, the effects are dose-dependent, and optimal concentrations appear to vary by context, underscoring the need for application-specific protocols
Call (860) 200-0249 to schedule an educational consultation to learn more about ipamorelin peptide therapy